Indian Pharma firms grew faster at 7 percent compared to 4 percent of MNCs in 2022: IQVIA Farhat Nasim8 March 2023 1:45 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has reflected growth of 7 percent in the year 2022 with overall IPM market size at Rs 1,93,838 crore...
How Vildagliptin Improves Time in Range in T2DM patients ft-Prof. Dr Aravinda Jagadeesha Dr. Nandita Mohan10 Jan 2023 11:00 AM IST The increased alpha and beta cell sensitivity to glucose by DPP4 inhibitors modulate not only chronic hyperglycemia but also daily glucose...
Safety and Efficacy of Vildagliptin 100mg SR- Ft. Prof. Dr Aravinda Jagadeesha Dr. Nandita Mohan15 Dec 2022 11:17 AM IST Among the gliptins, vildagliptin is the only therapy requiring twice-daily dosing and thus adversely impacts patient adherence. To reduce dosing...
Overviewing Cardiac Safety Profile of Vildagliptin 100mg SR -ft-Prof. Dr Aravinda Jagadeesha Dr. Nandita Mohan5 Dec 2022 12:00 PM IST Vildagliptin has established itself over the years by controlling the blood sugar levels in patients with type 2 diabetes mellitus. It is used along...
Hepatic Safety Profile of Vildagliptin 100 mg SR - Ft. Prof. Dr Aravinda Jagadeesha Dr. Nandita Mohan26 Nov 2022 12:33 PM IST Vildagliptin has established its efficacy over the years by displaying significant HbA1c lowering accompanied by body weight-neutral and...
Dr. Reddy proposal to market antidiabetic FDC of Imeglimin and Vildagliptin rejected by CDSCO Panel Dr. Divya Colin2 Nov 2022 6:00 PM ISTNew Delhi: Noting that the clinical experience with the drug Imeglimin is very limited, the Subject Expert Committee (SEC) functional under the...
Diabetes Leader USV slashes price of its popular Diabetes Medicine JALRA OD Dr. Nandita Mohan3 Oct 2022 12:45 PM ISTMumbai: With an aim to make its popular antidiabetic medicine more affordable and accessible to the Indian population, leading pharma company USV...
Once Daily Vildagliptin 100 mg sustained-release therapeutically safe, effective as Vildagliptin 50 mg twice daily add on to Metformin in Indian Diabetics Lalhmangaihkimi12 Aug 2022 12:30 PM ISTVildagliptin 100 mg sustained-release once daily is therapeutically safe and effective as Vildagliptin 50 mg tablet twice daily as an add-on to...
Once Daily Vildagliptin 100 mg SR as safe, effective as Vildagliptin 50 mg twice daily add on to Metformin in Indian Diabetics: Discussion on Indian Study Results Dr. Nandita Mohan26 July 2022 12:45 PM IST Vildagliptin, an oral hypoglycemic agent, acts by inhibiting the dipeptidyl peptidase-4 enzyme. The clinical efficacy and safety of vildagliptin...
Glenmark gets CDSCO panel nod for Phase 4 study of anti-diabetic FDC drug Dr. Divya Colin21 March 2022 6:37 PM ISTNew Delhi: In line with the drug major Glenmark Pharmaceutical's revised Phase IV clinical trial protocol for anti-diabetic fixed dose combination...
Health Bulletin 28/October/2021 Roshni Dhar28 Oct 2021 10:52 AM ISTHere are Top Health Stories of the dayNMC to do away with positions of Tutor, Demonstrator, Registrar, bring them all under Senior Resident...
Glenmark launches Remogliflozin, Vildagliptin, Metformin FDC at Rs 16.50 per tablet Ruchika Sharma26 Oct 2021 1:35 PM ISTMumbai: Drugmaker, Glenmark Pharmaceuticals Limited, today announced that the company has launched a fixed dose combination (FDC) of its novel, patent...
